Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors: Analysis of 108 patients

Strahlentherapie und Onkologie

Volumn 184, Issue 1, 2008, Pages 36-40

  Jereczek Fossa, Barbara A ^a,b   Kowalczyk, Anna ^a,c   D'Onofrio, Alberto ^a   Catalano, Gianpiero ^a   Garibaldi, Cristina ^a   Boboc, Genoveva ^a   Vitolo, Viviana ^a   Leonardi, Maria Cristina ^a   Cambria, Raffaella ^a   Orecchia, Roberto ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Recurrent; Reirradiation; Retreatment; Second primary; Second course radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; RADIATION DOSE; RECURRENT CANCER; REIRRADIATION; RETREATMENT; SECOND CANCER; STEREOTACTIC PROCEDURE; TREATMENT OUTCOME; TREATMENT PLANNING; URINARY TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PALLIATIVE CARE; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETREATMENT; SURVIVAL RATE;

EID: 38149128170     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1783-9     Document Type: Article

References (28)

1. Aykuzawa F, Shibuya H, Yoshimura RI, et al. Curative brachytherapy for recurrent/residual tongue cancer. Strahlenther Onkol 2007;183:133-7.
2. Bottke D, Bathe K, Wiegel T, et al. Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck. Strahlenther Onkol 2007;183:128-32.
3. Combs SE, Gutwein S, Thilmann C, et al. Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT). Strahlenther Onkol 2005;181:768-73.
4. Dawson LA, Myers LL, Bradford CR, et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:377-85.
5. Ernst-Stecken A, Lambrecht U, Mueller R, et al. Dose escalation in large anterior skull-base tumors by means of IMRT. First experience with the Novalis system. Strahlenther Onkol 2006;182:183-9.
6. Harms W, Krempien R, Grehn C, et al. [Reirradiation of chest wall recurrences from breast cancer.] Zentralbl Gynäkol 2004;126:19-23.
7. Hepel JT, Syed AM, Puthawala A, et al. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005;62:1444-50.
8. ICRU. Report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). Bethesda: International Commission on Radiation Units and Measurements, 1999.
9. Jereczek-Fossa BA, Krengli M, Orecchia R. Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience. Head Neck 2006;28:750-60.
10. Juffermans JH, Hanssens PE, van Putten WL, et al. Reirradiation and hyperthermia in rectal carcinoma: a retrospective study on palliative effect. Cancer 2003;98:1759-66.
11. Kao J, Garofalo MC, Milano MT, et al. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev 2003;29:21-30.
12. 192Ir HDR brachytherapy. Strahlenther Onkol 2007;183:69-75.
13. Kramer NM, Horwitz EM, Cheng J, et al. Toxicity and outcome analysis with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies. Head Neck 2005;27:406-14.
14. Langendijk JA, Kasperts N, Leemans CR, et al. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck. Radiother Oncol 2006;78:306-12.
15. Lengyel E, Baricza K, Somogyi A, et al. Reirradiation of locally recurrent nasopharyngeal carcinoma. Strahlenther Onkol 2003;179:298-305.
16. Machtay M, Rosenthal DI, Chalian AA, et al. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;59:72-7.
17. Mayer R, Hamilton-Farrell MR, van der Kleij AJ, et al. Hyperbaric oxygen and radiotherapy. Strahlenther Onkol 2005;181:113-23.
18. Mayer A, Naszaly A, Patyanik M, et al. Perioperative brachytherapy for pretreated chest wall recurrence of breast cancer. Strahlenther Onkol 2002;178:633-6.
19. Nieder C, Price RE, Rivera B, et al. Effects of insulin-like growth factor-1 (IGF-1) and amifostine in spinal cord reirradiation. Strahlenther Onkol 2005;181:691-5.
20. Oksuz DC, Meral G, Uzel O, et al. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 2004;60:388-94.
21. Orecchia R, Airoldi M, Sola B, et al. Results of chemotherapy plus external reirradiation in the treatment of locally advanced recurrences of nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol 1992;28:109-11.
22. Rades D, Stalpers LJ, Veninga T, et al. [Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC).] Strahlenther Onkol 2005;181:595-600.
23. Schaefer U, Micke O, Schueller P, et al. Recurrent head and neck cancer: Retreatment of previously irradiated areas with combined chemotherapy and radiation therapy - results of prospective study. Radiology 2000;216:371-6.
24. Schulz-Ertner D, Nikoghosyan A, Thilmann C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys 2004;58:631-40.
25. Selvin S. Modern applied biostatistical Methods using S-PLUS. Oxford: Oxford University Press, 1998.
26. Wang CC. To reirradiate or not to reirradiate? Int J Radiat Oncol Biol Phys 1994;29:913.
27. Wu KL, Jiang GL, Qian H, et al. Three-dimensional conformal radiotherapy for locoregional recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial. Int J Radiat Oncol Biol Phys 2003;57:1345-50.
28. Yue NJ, Knisley JP, Studholme C, et al. A technique to re-establish dose distributions for previously treated brain cancer patients in external beam radiotherapy. Med Dosim 2004;29:31-41.